Pembrolizumab in Triple-Negative Breast Cancer

Ryan Sun; Lee Jen Wei

doi:10.1056/NEJMc2210919

Pembrolizumab in Triple-Negative Breast Cancer

Ryan Sun, Lee Jen Wei

Biostatistics

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1435-1436
Number of pages	2
Journal	New England Journal of Medicine
Volume	387
Issue number	15
DOIs	https://doi.org/10.1056/NEJMc2210919
State	Published - Oct 13 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc2210919

Cite this

@article{726b0db89ea04d27868ced206f666c77,

title = "Pembrolizumab in Triple-Negative Breast Cancer",

author = "Ryan Sun and Wei, {Lee Jen}",

year = "2022",

month = oct,

day = "13",

doi = "10.1056/NEJMc2210919",

language = "English (US)",

volume = "387",

pages = "1435--1436",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Pembrolizumab in Triple-Negative Breast Cancer

AU - Sun, Ryan

AU - Wei, Lee Jen

PY - 2022/10/13

Y1 - 2022/10/13

UR - http://www.scopus.com/inward/record.url?scp=85140144776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140144776&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2210919

DO - 10.1056/NEJMc2210919

M3 - Letter

C2 - 36239657

AN - SCOPUS:85140144776

SN - 0028-4793

VL - 387

SP - 1435

EP - 1436

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 15

ER -

Pembrolizumab in Triple-Negative Breast Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this